StockData
Oric Pharmaceuticals, Inc. logo

Oric Pharmaceuticals, Inc. (ORIC) stock

ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$8.00+0.48 (+6.38%)

Close on Nov 17, 2026Market cap $829.22MP/E –Yield –

Oric Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Oric Pharmaceuticals's price to book ratio was 2.4× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 0.4× to 3.7×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.4×+0.5
2025Dec 31, 20252.0×−0.1
2024Dec 31, 20242.1×+0.1
2023Dec 29, 20232.0×+0.9
2022Dec 30, 20221.1×−0.9
2021Dec 31, 20212.0×−3.6
2020Dec 31, 20205.6×–

More Oric Pharmaceuticals figures

See a number that looks wrong?